News

Many lung cancers in nonsmokers have no known cause and are discovered only by chance.
AI model calculates a protein-based stemness index to predict tumor aggressiveness and treatment resistance. Proteomic-based ...
Integrated pharmacokinetics (PK), exposure-response, safety, and efficacy data supported 6 mg/kg Q3W as the recommended Phase 2 dose (RP2D) of IBI343. This provides support for the conduct of ...
Verastem's FDA approval for KRAS-mutant LGSOC, strong pipeline, and catalysts signal growth potential. Click here to read an ...
Melanoma, the most serious skin cancer, claims thousands of lives yearly, with men dying at a higher rate due to delayed detection and treatment. Jim Crooks was shocked by his diagnosis, having no ...
Cancer can sadly affect anyone and everyone, and the signs of cancer being present in the body can vary. Recently, Redditor u ...
As cancer cases have increased worldwide, the disease has become more complex, presenting challenges to scientific advances in diagnosis and treatment.
As cancer cases have increased worldwide, the disease has become more complex, presenting challenges to scientific advances ...
With EAGLE, lung cancer biopsy analysis is expedited, accurately predicting EGFR mutations and streamlining the diagnostic process for better patient outcomes.
The selection of a first-line treatment for patients with advanced EGFR -positive non-small cell lung cancer (NSCLC) has ...
(NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the European Commission has approved TEVIMBRA ® (tislelizumab), in combination with gemcitabine and cisplatin, ...